Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 01, 2024 07:00 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics Announces Changes to its Board of Directors

Autolus Therapeutics Announces Changes to its Board of Directors
March 14, 2024 07:00 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics Reports Full Year 2023 Financial Results and Business Updates

Autolus Therapeutics Reports Full Year 2023 Financial Results and Business Updates
March 12, 2024 07:00 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics receives Medicines and Healthcare products Regulatory Agency (MHRA) certification for Nucleus commercial manufacturing site

Autolus Therapeutics receives Medicines and Healthcare products Regulatory Agency (MHRA) certification for Nucleus commercial manufacturing site
March 11, 2024 07:00 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics announces publication in Blood Cancer Journal

Autolus Therapeutics announces publication in Blood Cancer Journal
February 29, 2024 07:00 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics to Report Full Year 2023 Financial Results and Business Updates on March 14, 2024

Autolus Therapeutics to Report Full Year 2023 Financial Results and Business Updates on March 14, 2024
February 22, 2024 07:00 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics announces publication in Nature Communications

Autolus Therapeutics announces publication in Nature Communications
February 08, 2024 07:00 ET | Source: Autolus Therapeutics plc

Autolus Announces Pricing of Underwritten Offering

Autolus Announces Pricing of Underwritten Offering
February 08, 2024 05:45 ET | Source: Autolus Therapeutics plc; BioNTech SE

BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs

BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
January 23, 2024 07:00 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics announces publication in ACS Chemical Biology

Autolus Therapeutics announces publication in ACS Chemical Biology
January 22, 2024 07:00 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics announces acceptance of Biologics License Application for obecabtagene autoleucel (obe-cel) as a potential treatment for relapsed/refractory Adult B-cell Acute Lymphoblastic Leukemia (ALL)

Autolus Therapeutics announces acceptance of BLA for obe-cel as a potential treatment for relapsed/refractory adult ALL